(Q74317164)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10988358%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Deferoxamine reduces tissue injury and lethality in LPS-treated mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10988358%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

M Vulcano

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10988358%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

R P Meiss

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10988358%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M A Isturiz

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10988358%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10988358%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Immunopharmacology

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10988358%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10988358%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10988358%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

635-644

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10988358%20AND%20SRC:MED&resulttype=core&format=json

Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Sepsis, the sepsis syndrome, multi-organ failure: a plea for comparable definitions

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Septic shock: pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Concordance of endotoxemia with gram-negative bacteremia in patients with gram-negative sepsis: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Interactions of granulocytes with the lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Shock and tissue injury induced by recombinant human cachectin

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Tumor necrosis, cachexia, shock, and inflammation: a common mediator

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

The biology of cachectin/TNF--a primary mediator of the host response

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

The pathophysiology of tumor necrosis factors

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Anti-endotoxin monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Oxygen radicals, inflammation, and tissue injury

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Regulation of cytokine gene expression by reactive oxygen and reactive nitrogen intermediates.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review)

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

The effects of intravenous antioxidants in patients with septic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Excessive liver oxidant stress causes mortality in response to burn injury combined with endotoxin and is prevented with antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Oxygen toxicity, oxygen radicals, transition metals and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-alpha response from alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

The role of free radicals in asbestos-induced diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Molecular cloning of the complementary DNA for human tumor necrosis factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Galactosamine-induced sensitization to the lethal effects of endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Ascorbyl radical formation in patients with sepsis: effect of ascorbate loading.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Xanthine oxidase activity and free radical generation in patients with sepsis syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Hydroxyl radical scavengers inhibit TNF-alpha production in mononuclear cells but not in polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Regulation of monokine gene expression: prostaglandin E2 suppresses tumor necrosis factor but not interleukin-1 alpha or beta-mRNA and cell-associated bioactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Modulation of endothelial cell hemostatic properties by tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Tumor necrosis factor provokes superoxide anion generation from neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

Fc gamma receptor-dependent clearance is enhanced following lipopolysaccharide in vivo treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900026-6

7 January 2021

10.1016/S0192-0561(00)00026-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10988358%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference